Showing results (61-70 of 167) with videos related to

Sort By:
Pageof 17
Biorxiv : the Preprint Server for Biology|September 24, 2024
Desmoplakin mutations in cardiac fibroblasts cause TGFβ1-mediated pathological fibrogenesis in desmoplakin cardiomyopathy via beclin-1 regulationChuanyu Wei, Shing-Fai Chan, Ardan M Saguner, et al.
Journal of Genetic Counseling|October 7, 2024
Randomized control trial comparing genetic counseling service delivery models in an underserved populationSayoni Lahiri, Jacqueline Mersch, John Zimmerman, et al.
Journal of the American College of Cardiology|September 24, 2011
Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary preventionAditya Bhonsale, Cynthia A James, Crystal Tichnell, et al.
Heart Rhythm|January 1, 2025
Endurance exercise promotes episodes of myocardial injury in individuals with a pathogenic desmoplakin (DSP) variantAlan P Jacobsen, Katia Chiampas, Steven A Muller, et al.
Circulation. Arrhythmia and Electrophysiology|March 4, 2014
Arrhythmogenic right ventricular dysplasia/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclearBinu Philips, Srinivasa Madhavan, Cynthia A James, et al.
Journal of the American Heart Association|June 8, 2017
Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and ComplicationsGabriela M Orgeron, Cynthia A James, Anneline Te Riele, et al.
Circulation. Arrhythmia and Electrophysiology|February 18, 2018
Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/CardiomyopathyGabriela M Orgeron, Anneline Te Riele, Crystal Tichnell, et al.
Heart Rhythm|December 23, 2014
Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathyBinu Philips, Anneline S J M te Riele, Abhishek Sawant, et al.
Heart Rhythm|February 7, 2018
Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysisLaurens P Bosman, Arjan Sammani, Cynthia A James, et al.
Radiology|March 12, 2016
Fibrofatty Changes: Incidence at Cardiac MR Imaging in Patients with Arrhythmogenic Right Ventricular Dysplasia/CardiomyopathyNeda Rastegar, Anneline S J M Te Riele, Cynthia A James, et al.
Pageof 17